Rebiotix Revenue and Competitors
Estimated Revenue & Valuation
- Rebiotix's estimated annual revenue is currently $16.4M per year.
- Rebiotix received $8.5M in venture funding in September 2017.
- Rebiotix's estimated revenue per employee is $155,000
- Rebiotix's total funding is $39.1M.
- Rebiotix has 106 Employees.
- Rebiotix grew their employee count by 10% last year.
Rebiotix Competitors & Alternatives
|Competitor Name||Revenue||Number of Employees||Employee Growth||Total Funding||Valuation|
What Is Rebiotix?
Rebiotix Inc is a clinical-stage biotechnology company revolutionizing the treatment of challenging gastrointestinal diseases by harnessing the power of the human microbiome. Our highly skilled and dynamic team is based out of Roseville, Minnesota. Please feel free to contact us through our website at www.rebiotix.com.keywords:Biotechnology,Healthcare,Pharmaceuticals
Number of Employees
Employee Growth %
A stool-based enema composed of a broad variety of microbes (RBX2660, Rebiotix/Ferring) was up to 84% effective in reducing recurrent Clostridioides...
RBX2660 (Rebiotix); SER-109 (Seres Therapeutics); CP-101 (Finch Therapeutics); VE303 (Vedanta Biosciences); NTCD M3 (Destiny Pharmaceuticals)...
The project, comprising mixed bacterial consortia, was originated by Rebiotix, a US biotech that Ferring bought in 2018.
ROSEVILLE, Minn.--(BUSINESS WIRE)-- Rebiotix Inc, a Ferring Pharmaceuticals company, announced today that their Chief Scientific Officer, ...
|Company Name||Revenue||Number of Employees||Employee Growth||Total Funding|